Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update

Go back to Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update
(NASDAQ: TSHA) Delayed: 3.86 -0.15 (3.74%)
Previous Close $4.01    52 Week High $ 
Open $3.95    52 Week Low $ 
Day High $3.95    P/E N/A 
Day Low $3.76    EPS $ 
Volume 866,793